The Advanced Therapies Summit is a gathering of top executives and clinical researchers from across Europe and the U.S.
The Advanced Therapies Summit is a multi-stakeholder, interactive forum that seeks to exchange views and make recommendations on how best to advance the ATMP sector in Europe. The conference brings together the top executives, clinical researchers, public policy makers and other members of the advanced therapies community to highlight the major achievements as well as the main challenges experienced along the path from discovery to delivery of transformative – and even potentially curative – therapies.
The Cell and Gene Therapy Catapult team will be taking part in the following discussions at the meeting:
Keith Thompson, Cell and Gene Therapy Catapult CEO, will be providing state of the industry remarks to open the event.
Dr Jacqueline Barry, Chief Clinical Officer will be participating in a roundtable titled fostering regulatory development and improving patient access to ATMPs in Europe, Wednesday 22 March, 9:30am.
Matthew Durdy, Chief Business Office at Cell and Gene Therapy Catapult will be moderating a discussion on capital formation and the investor’s assessment of advanced therapies, Wednesday 22 March, 11:45am.